F. Woltering

发表

Effect of using a wearable device on clinical decision-making and motor symptoms in patients with Parkinson's disease starting transdermal rotigotine patch: A pilot study.

Babak Boroojerdi, Olga Waln, Fredy J. Revilla, 2019, Parkinsonism & related disorders.

Impact of Certolizumab Pegol on Patient‐Reported Outcomes in Patients With Axial Spondyloarthritis

R. Landewé, A. Deodhar, A. Kivitz, 2015, Arthritis care & research.

Impact of 6-month earlier versus postponed initiation of rotigotine on long-term outcome: post hoc analysis of patients with early Parkinson’s disease with mild symptom severity

L. Timmermann, B. Boroojerdi, L. Elmer, 2015, Expert opinion on pharmacotherapy.

Effect of different imputation approaches on the evaluation of radiographic progression in patients with psoriatic arthritis: results of the RAPID-PsA 24-week phase III double-blind randomised placebo-controlled study of certolizumab pegol

D. M. van der Heijde, D. Heijde, A. Deodhar, 2013, Annals of the rheumatic diseases.

Treadmill testing for evaluation of claudication: comparison of constant-load and graded-exercise tests.

M. Cachovan, P. Scheffler, C. Diehm, 1997, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA)

D. M. van der Heijde, D. Heijde, A. Deodhar, 2013, Annals of the rheumatic diseases.

Effect of Certolizumab Pegol on Multiple Facets of Psoriatic Arthritis as Reported by Patients: 24-Week Patient-Reported Outcome Results of a Phase III, Multicenter Study

D. Gladman, P. Mease, R. Fleischmann, 2014, Arthritis care & research.

EFFECT OF CERTOLIZUMAB PEGOL ON SIGNS AND SYMPTOMS IN PATIENTS WITH PSORIATIC ARTHRITIS WITH OR WITHOUT PRIOR ANTI-TNF EXPOSURE : 24-WEEK RESULTS OF A PHASE III DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED STUDY

P. Mease, R. Fleischmann, D. Kielar, 2012 .

Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopenia.

J. Bussel, T. Robak, Juan Ke, 2020, Blood advances.

Efficacy and Safety of Rozanolixizumab in Moderate to Severe Generalized Myasthenia Gravis

M. Benatar, J. Vissing, V. Bril, 2020, Neurology.

Proof-of-Concept and Safety of the Anti-FcRn Antibody Rozanolixizumab in Patients with Moderate-to-Severe Generalized Myasthenia Gravis (GMG): A Phase 2a Study (S43.001)

M. Benatar, P. Bergh, V. Bril, 2019 .

Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

Denny J. Padgett, Adam L. Comer, Yi-Chung Lee, 2023, The Lancet Neurology.

Prevention of Contrast Media-Induced Renal Dysfunction With Prostaglandin E 1 : A Randomized, Double-Blind, Placebo-Controlled Study

J. Brinker, P. Bernink, J. Koch, 2001, American journal of therapeutics.

Efficacy of Rotigotine at Different Stages of Parkinson’s Disease Symptom Severity and Disability: A Post Hoc Analysis According to Baseline Hoehn and Yahr Stage

W. Poewe, Nir Giladi, A. Nicholas, 2016, Journal of Parkinson's disease.

Rapid Improvements In Patient-Reported Outcomes With Certolizumab Pegol In Patients With Axial Spondyloarthritis, Including Ankylosing Spondylitis And Non-Radiographic Axial Spondyloarthritis: 24-Week Results Of A Phase 3 Double Blind Randomized Placebo-Controlled Study

A. Deodhar, A. Kivitz, G. Coteur, 2013 .

Effect Of Certolizumab Pegol On The Multiple Facets Of Psoriatic Arthritis As Reported By Patients: 24-Week Patient Reported Outcome Results Of A Phase 3 Double Blind Randomized Placebo-Controlled Study

D. Gladman, P. Mease, R. Fleischmann, 2013 .

Rozanolixizumab, an Anti-FcRn Antibody: Final Results from a Phase II, Multiple-Dose Study in Patients with Primary Immune Thrombocytopenia

J. Bussel, T. Robak, Juan Ke, 2019, Blood.

Randomized Reliability Study Evaluating Constant-load and Graded-exercise Treadmill Test for Intermittent Claudication

M. Cachovan, P. Scheffler, C. Diehm, 1999, Angiology.